Player is loading...
Pitch Medicud
Thursday, Dec. 3, 2020 · 4:20 p.m. · 01m 36s
Embed
Transcriptions
Note: this content has been automatically generated.
00:00:00
many men isn't it i'm so and then it's you encounter many good
00:00:06
do you know the enemy here more than one hundred and fifty maiden patient that will
00:00:10
open exuding working which is an ascii medical condition that tends to get infected really easy
00:00:17
a complication can the implication of bullying or even the death of the passion after sets is
00:00:24
i don't think there's a solution and is the negative pressure would
00:00:28
sure be is the goal some other treatment since the late nineties
00:00:32
but it does some issues limiting the global induction course of once you've expensive we're
00:00:39
talking about three hundred fronts were we can treatment and the treatment can easily exceed
00:00:45
one more then the devices are not user friendly and at the end of the
00:00:49
day the device is not ecological i'm any good with only calico powered section device
00:00:56
good using exactly the same performance is also actually
00:01:00
counterparts but attraction the cost and as you can see
00:01:04
it's really small it's easier prey that uh if one thing you're sober user friendly we produce and that device
00:01:13
for advanced medication you know to provide something good for people around the world no mother that it in
00:01:21
switzerland you as south africa kenya or whatever everybody has
00:01:26
the right to be treated yeah i just found out
Conference Program
Welcome from the Sponsors
La Forge - InnoPeaks - Hewlett Packard - Pulse Incubateur HES - Geneus
Dec. 3, 2020 · 2:10 p.m.
Keynote - Sophia Genetics
Jurgi Camblong, CEO, Sophie Genetics
Dec. 3, 2020 · 2:20 p.m.
139 views
Q&A - Sophia Genetics
Jurgi Camblong, CEO, Sophie Genetics
Dec. 3, 2020 · 2:50 p.m.
115 views
